Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3021% above fair value
$19.10−0.30 (-1.55%)
Close on Nov 13, 2026Market cap $931.24MP/E –Yield –
Artivion total assets
Total assets on the balance sheet at the end of each period.
Artivion's total assets was $1.04B at Sep 30, 2026. For fiscal 2025 it was $884.80M, up 12.1% from the year before. Over ten years it grew 17.2% a year on average. The highest annual figure on record is $884.80M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $884.80M | +12.1% |
| FY2024 | Dec 31, 2024 | $789.10M | -0.4% |
| FY2023 | Dec 31, 2023 | $792.40M | +3.9% |
| FY2022 | Dec 31, 2022 | $762.80M | -3.8% |
| FY2021 | Dec 31, 2021 | $793.05M | +0.5% |
| FY2020 | Dec 31, 2020 | $789.40M | +30.3% |
| FY2019 | Dec 31, 2019 | $605.65M | +6.1% |
| FY2018 | Dec 31, 2018 | $571.09M | -3.2% |
| FY2017 | Dec 31, 2017 | $589.69M | +86.5% |
| FY2016 | Dec 31, 2016 | $316.14M | +74.5% |
| FY2015 | Dec 31, 2015 | $181.18M | +2.9% |
| FY2014 | Dec 31, 2014 | $176.16M | +0.8% |
| FY2013 | Dec 31, 2013 | $174.68M | +11.2% |
| FY2012 | Dec 31, 2012 | $157.16M | +6.3% |
| FY2011 | Dec 31, 2011 | $147.86M | +7.6% |
| FY2010 | Dec 31, 2010 | $137.44M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.04B | +21.5% |
| Q2 FY2026 | Jun 30, 2026 | $1.07B | +27.9% |
| Q1 FY2026 | Mar 31, 2026 | $883.16M | +11.6% |
| Q4 FY2025 | Dec 31, 2025 | $884.80M | +12.1% |
| Q3 FY2025 | Sep 30, 2025 | $857.66M | +6.8% |
| Q2 FY2025 | Jun 30, 2025 | $838.39M | +6.2% |
| Q1 FY2025 | Mar 31, 2025 | $791.16M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $789.10M | -0.4% |
| Q3 FY2024 | Sep 30, 2024 | $803.14M | +3.7% |
| Q2 FY2024 | Jun 30, 2024 | $789.54M | +1.5% |
| Q1 FY2024 | Mar 31, 2024 | $784.01M | +3.6% |
| Q4 FY2023 | Dec 31, 2023 | $792.40M | +3.9% |
| Q3 FY2023 | Sep 30, 2023 | $774.79M | +4.3% |
| Q2 FY2023 | Jun 30, 2023 | $777.86M | +1.7% |
| Q1 FY2023 | Mar 31, 2023 | $757.07M | -3.2% |
| Q4 FY2022 | Dec 31, 2022 | $762.80M | -3.8% |
| Q3 FY2022 | Sep 30, 2022 | $742.73M | -9.3% |
| Q2 FY2022 | Jun 30, 2022 | $764.86M | -5.6% |
| Q1 FY2022 | Mar 31, 2022 | $781.86M | -1.6% |
| Q4 FY2021 | Dec 31, 2021 | $793.05M | +0.5% |
| Q3 FY2021 | Sep 30, 2021 | $818.65M | +4.7% |
| Q2 FY2021 | Jun 30, 2021 | $810.50M | +16.9% |
| Q1 FY2021 | Mar 31, 2021 | $794.83M | +28.0% |
| Q4 FY2020 | Dec 31, 2020 | $789.40M | +30.3% |
| Q3 FY2020 | Sep 30, 2020 | $782.20M | +32.0% |
| Q2 FY2020 | Jun 30, 2020 | $693.25M | +16.1% |
| Q1 FY2020 | Mar 31, 2020 | $621.03M | +5.8% |
| Q4 FY2019 | Dec 31, 2019 | $605.65M | +6.1% |
| Q3 FY2019 | Sep 30, 2019 | $592.60M | +4.0% |
| Q2 FY2019 | Jun 30, 2019 | $597.12M | +4.7% |
| Q1 FY2019 | Mar 31, 2019 | $586.93M | +0.6% |
| Q4 FY2018 | Dec 31, 2018 | $571.09M | -3.2% |
| Q3 FY2018 | Sep 30, 2018 | $569.70M | +74.7% |
| Q2 FY2018 | Jun 30, 2018 | $570.45M | +77.0% |
| Q1 FY2018 | Mar 31, 2018 | $583.18M | +82.6% |
| Q4 FY2017 | Dec 31, 2017 | $589.69M | +86.5% |
| Q3 FY2017 | Sep 30, 2017 | $326.14M | – |
| Q2 FY2017 | Jun 30, 2017 | $322.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $319.37M | – |
| Q4 FY2016 | Dec 31, 2016 | $316.14M | – |
See a number that looks wrong?